{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-268239","form_type":"8-K","ticker":"CTS","cik":"0000026058","company_name":"CTS CORP","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.639666+00:00","generated_at":"2026-05-17T00:03:48.870797+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"CTS appoints Kimberly Banks MacKay to board, effective Nov 5, 2025","bullets":["Board expands from 7 to 8 members; MacKay fills newly created vacancy.","MacKay is SVP, General Counsel & Corporate Secretary of West Pharmaceutical Services.","She will serve on Nominating, Governance & Sustainability and Technology & Transactions committees.","Compensation is consistent with other non-employee directors, per prior proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-268239","json":"https://secwatch.observer/filing/0001193125-25-268239.json","markdown":"https://secwatch.observer/filing/0001193125-25-268239.md","text":"https://secwatch.observer/filing/0001193125-25-268239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/26058/000119312525268239/0001193125-25-268239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/26058/000119312525268239/cts-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:03:48.870797+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}